{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:08:54Z","timestamp":1783480134538,"version":"3.55.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T00:00:00Z","timestamp":1311638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s11908-011-0202-z","type":"journal-article","created":{"date-parts":[[2011,7,25]],"date-time":"2011-07-25T04:44:18Z","timestamp":1311569058000},"page":"451-460","source":"Crossref","is-referenced-by-count":33,"title":["Advances in the Diagnosis and Management of Pediatric Osteomyelitis"],"prefix":"10.1007","volume":"13","author":[{"given":"Isaac","family":"Thomsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Buddy","family":"Creech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,26]]},"reference":[{"key":"202_CR1","volume-title":"Feigin and Cherry\u2019s textbook of pediatric infectious diseases","author":"P Krogstad","year":"2009","unstructured":"Krogstad P. Osteomyelitis. In: Feigin RD, Cherry JD, Kaplan SL, Demmler-Harrison GJ, editors. Feigin and Cherry\u2019s textbook of pediatric infectious diseases. Philadelphia: Saunders Elsevier; 2009."},{"key":"202_CR2","volume-title":"Textbook of pediatric emergency medicine","author":"GR Fleisher","year":"2010","unstructured":"Fleisher GR, Ludwig S. Textbook of pediatric emergency medicine. 6th ed. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins; 2010. xxx, 1970 p.","edition":"6"},{"issue":"1","key":"202_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00008480-200202000-00020","volume":"14","author":"M Vazquez","year":"2002","unstructured":"Vazquez M. Osteomyelitis in children. Curr Opin Pediatr. 2002;14(1):112\u20135.","journal-title":"Curr Opin Pediatr"},{"key":"202_CR4","volume-title":"Principles and practice of pediatric infectious diseases. 3rd rev. ed","author":"SS Long","year":"2008","unstructured":"Long SS, Pickering LK, Prober CG. Principles and practice of pediatric infectious diseases. 3rd rev. ed. Philadelphia: Churchill Livingstone\/Elsevier; 2008. xxxiii, 1618 p."},{"issue":"5","key":"202_CR5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/01241398-200009000-00025","volume":"20","author":"JB Chambers","year":"2000","unstructured":"Chambers JB, Forsythe DA, Bertrand SL, et al. Retrospective review of osteoarticular infections in a pediatric sickle cell age group. J Pediatr Orthop. 2000;20(5):682\u20135.","journal-title":"J Pediatr Orthop"},{"key":"202_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-0-387-79838-7_10","volume":"634","author":"SL Kaplan","year":"2009","unstructured":"Kaplan SL. Challenges in the evaluation and management of bone and joint infections and the role of new antibiotics for gram positive infections. Adv Exp Med Biol. 2009;634:111\u201320.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"202_CR7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1086\/507637","volume":"43","author":"PS Pannaraj","year":"2006","unstructured":"Pannaraj PS, Hulten KG, Gonzalez BE, et al. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006;43(8):953\u201360.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"202_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/01.bpo.0000242431.91489.b4","volume":"26","author":"SR Arnold","year":"2006","unstructured":"Arnold SR, Elias D, Buckingham SC, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop. 2006;26(6):703\u20138.","journal-title":"J Pediatr Orthop"},{"issue":"1","key":"202_CR9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/BPO.0b013e3181901c3a","volume":"29","author":"JJ Hawkshead","year":"2009","unstructured":"\u2022 Hawkshead JJ, Patel NB, Steele RW, Heinrich SD. Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus. J Pediatr Orthop. 2009;29(1):85\u201390. This retrospective study of 97 children with staphylococcal osteomyelitis suggests that MRSA osteomyelitis is more severe and requires more aggressive surgical and medical management.","journal-title":"J Pediatr Orthop"},{"key":"202_CR10","doi-asserted-by":"crossref","unstructured":"\u2022 Williams DJ, Deis JN, Tardy J, Creech CB. Culture-negative osteoarticular infections in the era of community-associated methicillin-resistant staphylococcus aureus. Pediatr Infect Dis J. 2011;30(6):523\u201325. This study showed that while culture-negative osteoarticular infections are milder compared with culture-positive infections, the duration of parenteral antibiotics for these infections has increased dramatically in recent years.","DOI":"10.1097\/INF.0b013e318207a7a5"},{"issue":"2","key":"202_CR11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1542\/peds.2005-0566","volume":"117","author":"CE Bocchini","year":"2006","unstructured":"Bocchini CE, Hulten KG, Mason EO, et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006;117(2):433\u201340.","journal-title":"Pediatrics"},{"issue":"1","key":"202_CR12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.diagmicrobio.2006.03.007","volume":"56","author":"K Moumile","year":"2006","unstructured":"Moumile K, Cadilhac C, Lina G, et al. Severe osteoarticular infection associated with Panton-Valentine leukocidin-producing Staphylococcus aureus. Diagn Microbiol Infect Dis. 2006;56(1):95\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"202_CR13","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/509506","volume":"194","author":"JM Voyich","year":"2006","unstructured":"Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis. 2006;194(12):1761\u201370.","journal-title":"J Infect Dis"},{"issue":"1","key":"202_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jinf.2009.05.003","volume":"59","author":"A Cunnington","year":"2009","unstructured":"Cunnington A, Brick T, Cooper M, et al. Severe invasive Panton-Valentine Leucocidin positive Staphylococcus aureus infections in children in London, UK. J Infect. 2009;59(1):28\u201336.","journal-title":"J Infect"},{"issue":"8","key":"202_CR15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/BPO.0b013e3181bd1e0c","volume":"29","author":"KL Vander Have","year":"2009","unstructured":"Vander Have KL, Karmazyn B, Verma M, et al. Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer. J Pediatr Orthop. 2009;29(8):927\u201331.","journal-title":"J Pediatr Orthop"},{"key":"202_CR16","first-page":"614","volume-title":"Manual of clinical microbiology","author":"AZR Graevenitz Von","year":"2003","unstructured":"Von Graevenitz AZR, Mutters R. Actinobacillus, Capnocytophaga, Eikenella, Kingella, Pasteurella, and other fastidious or rarely encountered gram-negative rods. In: Baron EJ, Murray PR, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology. Washington: American Society for Microbiology; 2003. p. 614\u20135."},{"issue":"2","key":"202_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e318184dbb8","volume":"28","author":"P Yagupsky","year":"2009","unstructured":"Yagupsky P, Porat N, Pinco E. Pharyngeal colonization by Kingella kingae in children with invasive disease. Pediatr Infect Dis J. 2009;28(2):155\u20137.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"202_CR18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1473-3099(04)01046-1","volume":"4","author":"P Yagupsky","year":"2004","unstructured":"Yagupsky P. Kingella kingae: from medical rarity to an emerging paediatric pathogen. Lancet Infect Dis. 2004;4(6):358\u201367.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"202_CR19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/INF.0b013e3181d57a6c","volume":"29","author":"G Dubnov-Raz","year":"2010","unstructured":"\u2022 Dubnov-Raz G, Ephros M, Garty B-Z, et al. Invasive pediatric Kingella kingae infections: a nationwide collaborative study. Pediatr Infect Dis J. 2010;29(7):639\u201343. This large study helped to define Kingella as an important pathogen in children age 6 to 36\u00a0months.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"202_CR20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1542\/peds.2010-1867","volume":"127","author":"P Yagupsky","year":"2011","unstructured":"\u2022 Yagupsky P, Porsch E, St. Geme 3rd JW. Kingella kingae: an emerging pathogen in young children. Pediatrics. 2011;127(3):557. These authors provide an excellent revew of Kingella kingae, including its importance as an etiology of osteomyelitis in young children.","journal-title":"Pediatrics"},{"issue":"8","key":"202_CR21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00006454-199508000-00005","volume":"14","author":"P Yagupsky","year":"1995","unstructured":"Yagupsky P, Dagan R, Prajgrod F, Merires M. Respiratory carriage of Kingella kingae among healthy children. Pediatr Infect Dis J. 1995;14(8):673\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"202_CR22","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1128\/JCM.33.5.1426-1427.1995","volume":"33","author":"P Yagupsky","year":"1995","unstructured":"Yagupsky P, Merires M, Bahar J, Dagan R. Evaluation of novel vancomycin-containing medium for primary isolation of Kingella kingae from upper respiratory tract specimens. J Clin Microbiol. 1995;33(5):1426\u20137.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"202_CR23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/INF.0b013e31819f1f36","volume":"28","author":"P Yagupsky","year":"2009","unstructured":"Yagupsky P, Weiss-Salz I, Fluss R, et al. Dissemination of Kingella kingae in the community and long-term persistence of invasive clones. Pediatr Infect Dis J. 2009;28(8):707\u201310.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"202_CR24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.inf.0000259954.88139.f4","volume":"26","author":"S Chometon","year":"2007","unstructured":"Chometon S, Benito Y, Chaker M, et al. Specific real-time polymerase chain reaction places Kingella kingae as the most common cause of osteoarticular infections in young children. Pediatr Infect Dis J. 2007;26(5):377\u201381.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"202_CR25","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11999-009-0936-1","volume":"468","author":"M P\u00e4\u00e4kk\u00f6nen","year":"2010","unstructured":"\u2022\u2022 P\u00e4\u00e4kk\u00f6nen M, Kallio MJT, Kallio PE, Peltola H. Sensitivity of erythrocyte sedimentation rate and C-reactive protein in childhood bone and joint infections. Clin Orthop Relat Res. 2010;468(3):861\u20136. This study examined the use of both ESR and CRP for initial diagnosis and monitoring of pediatric osteoarticular infection, finding that the combination of both tests maximizes the sensitivity, and demonstrating that CRP normalizes much more quickly.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"202_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.93.1.59","volume":"93","author":"L Unkila-Kallio","year":"1994","unstructured":"Unkila-Kallio L, Kallio MJ, Eskola J, Peltola H. Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics. 1994;93(1):59\u201362.","journal-title":"Pediatrics"},{"key":"202_CR27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/01.blo.0000057991.41099.47","volume":"409","author":"AG Khachatourians","year":"2003","unstructured":"Khachatourians AG, Patzakis MJ, Roidis N, Holtom PD. Laboratory monitoring in pediatric acute osteomyelitis and septic arthritis. Clin Orthop Relat Res. 2003;409:186\u201394.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"202_CR28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00006454-199501000-00008","volume":"14","author":"I Roine","year":"1995","unstructured":"Roine I, Faingezicht I, Arguedas A, et al. Serial serum C-reactive protein to monitor recovery from acute hematogenous osteomyelitis in children. Pediatr Infect Dis J. 1995;14(1):40\u20134.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"202_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0029-1237693","volume":"13","author":"M Ranson","year":"2009","unstructured":"\u2022 Ranson M. Imaging of pediatric musculoskeletal infection. Semin Musculoskelet Radiol. 2009;13(3):277\u201399. This is an excellent review of imaging modalities for pediatric bone and joint infections.","journal-title":"Semin Musculoskelet Radiol"},{"issue":"8","key":"202_CR30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00247-008-0888-8","volume":"38","author":"LP Browne","year":"2008","unstructured":"Browne LP, Mason EO, Kaplan SL, et al. Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol. 2008;38(8):841\u20137.","journal-title":"Pediatr Radiol"},{"issue":"3","key":"202_CR31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/RMR.0b0318123eee56","volume":"18","author":"RK Lalam","year":"2007","unstructured":"Lalam RK, Cassar-Pullicino VN, Tins BJ. Magnetic resonance imaging of appendicular musculoskeletal infection. Top Magn Reson Imag. 2007;18(3):177\u201391.","journal-title":"Top Magn Reson Imag"},{"issue":"2","key":"202_CR32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2214\/ajr.165.2.7618566","volume":"165","author":"D Jaramillo","year":"1995","unstructured":"Jaramillo D, Treves ST, Kasser JR, et al. Osteomyelitis and septic arthritis in children: appropriate use of imaging to guide treatment. AJR Am J Roentgenol. 1995;165(2):399\u2013403.","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"202_CR33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01241398-199503000-00002","volume":"15","author":"JM Mazur","year":"1995","unstructured":"Mazur JM, Ross G, Cummings J, et al. Usefulness of magnetic resonance imaging for the diagnosis of acute musculoskeletal infections in children. J Pediatr Orthop. 1995;15(2):144\u20137.","journal-title":"J Pediatr Orthop"},{"issue":"4","key":"202_CR34","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2214\/AJR.07.2416","volume":"189","author":"SA Connolly","year":"2007","unstructured":"Connolly SA, Connolly LP, Drubach LA, et al. MRI for detection of abscess in acute osteomyelitis of the pelvis in children. AJR Am J Roentgenol. 2007;189(4):867\u201372.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"202_CR35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/BPO.0b013e3181fcbae5","volume":"30","author":"PM Courtney","year":"2010","unstructured":"\u2022 Courtney PM, Flynn JM, Jaramillo D, et al. Clinical indications for repeat MRI in children with acute hematogenous osteomyelitis. J Pediatr Orthop. 2010;30(8):883\u20137. This study found that a repeat MRI did not have a useful role in the routine management of pediatric AHO, though it may be helpful in patients who are not improving on standard therapy.","journal-title":"J Pediatr Orthop"},{"issue":"9","key":"202_CR36","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.inf.0000083848.93457.e7","volume":"22","author":"K Moumile","year":"2003","unstructured":"Moumile K, Merckx J, Glorion C, et al. Osteoarticular infections caused by Kingella kingae in children: contribution of polymerase chain reaction to the microbiologic diagnosis. Pediatr Infect Dis J. 2003;22(9):837\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"202_CR37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/01.inf.0000172153.10569.dc","volume":"24","author":"I Verdier","year":"2005","unstructured":"Verdier I, Gayet-Ageron A, Ploton C, et al. Contribution of a broad range polymerase chain reaction to the diagnosis of osteoarticular infections caused by Kingella kingae: description of twenty-four recent pediatric diagnoses. Pediatr Infect Dis J. 2005;24(8):692\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"202_CR38","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1128\/JCM.00144-09","volume":"47","author":"B Ilharreborde","year":"2009","unstructured":"Ilharreborde B, Bidet P, Lorrot M, et al. New real-time PCR-based method for Kingella kingae DNA detection: application to samples collected from 89 children with acute arthritis. J Clin Microbiol. 2009;47(6):1837\u201341.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"202_CR39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.mimet.2006.06.010","volume":"68","author":"AL Rosey","year":"2007","unstructured":"Rosey AL, Abachin E, Quesnes G, et al. Development of a broad-range 16S rDNA real-time PCR for the diagnosis of septic arthritis in children. J Microbiol Meth. 2007;68(1):88\u201393.","journal-title":"J Microbiol Meth"},{"issue":"4","key":"202_CR40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/BOR.0b013e3283032030","volume":"20","author":"F Fenollar","year":"2008","unstructured":"Fenollar F, L\u00e9vy P-Y, Raoult D. Usefulness of broad-range PCR for the diagnosis of osteoarticular infections. Curr Opin Rheumatol. 2008;20(4):463\u201370.","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"202_CR41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1128\/JCM.44.3.1018-1028.2006","volume":"44","author":"F Fenollar","year":"2006","unstructured":"Fenollar F, Roux V, Stein A, et al. Analysis of 525 samples to determine the usefulness of PCR amplification and sequencing of the 16S rRNA gene for diagnosis of bone and joint infections. J Clin Microbiol. 2006;44(3):1018\u201328.","journal-title":"J Clin Microbiol"},{"key":"202_CR42","doi-asserted-by":"crossref","unstructured":"Fihman V, Hannouche D, Bousson V, et al. Improved diagnosis specificity in bone and joint infections using molecular techniques. J Infect. 2007;55(6):510\u201317.","DOI":"10.1016\/j.jinf.2007.09.001"},{"issue":"3","key":"202_CR43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(01)00094-9","volume":"1","author":"D Stengel","year":"2001","unstructured":"Stengel D, Bauwens K, Sehouli J, et al. Systematic review and meta-analysis of antibiotic therapy for bone and joint infections. Lancet Infect Dis. 2001;1(3):175\u201388.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"202_CR44","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.idc.2005.05.011","volume":"19","author":"SL Kaplan","year":"2005","unstructured":"Kaplan SL. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am. 2005;19(3):747\u201357.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"202_CR45","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CMR.00081-09","volume":"23","author":"MZ David","year":"2010","unstructured":"David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23(3):616\u201387.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"202_CR46","doi-asserted-by":"crossref","first-page":"e1294","DOI":"10.1542\/peds.2009-2867","volume":"125","author":"JC Herigon","year":"2010","unstructured":"\u2022 Herigon JC, Hersh AL, Gerber JS, et al. Antibiotic management of Staphylococcus aureus infections in US children\u2019s hospitals, 1999\u20132008. Pediatrics. 2010;125(6):e1294\u2013300. This paper examined antibiotic prescribing patterns over the last decade, finding that clindamycin is now the most common antibiotic prescribed for S. aureus infections in children, including osteomyelitis.","journal-title":"Pediatrics"},{"issue":"6","key":"202_CR47","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","volume":"42","author":"G Sakoulas","year":"2004","unstructured":"Sakoulas G, Moise-Broder PA, Schentag J, et al. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004;42(6):2398\u2013402.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"202_CR48","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.inf.0000171175.76673.64","volume":"24","author":"L Braun","year":"2005","unstructured":"Braun L, Craft D, Williams R, et al. Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities. Pediatr Infect Dis J. 2005;24(7):622\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"202_CR49","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/AAC.49.6.2283-2288.2005","volume":"49","author":"S Chavez-Bueno","year":"2005","unstructured":"Chavez-Bueno S, Bozdogan B, Katz K, et al. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother. 2005;49(6):2283\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"202_CR50","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1128\/JCM.02274-06","volume":"45","author":"LL Han","year":"2007","unstructured":"Han LL, McDougal LK, Gorwitz RJ, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol. 2007;45(4):1350\u20132.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"202_CR51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ajic.2008.09.015","volume":"37","author":"KM McMullen","year":"2009","unstructured":"McMullen KM, Warren DK, Woeltje KF. The changing susceptibilities of methicillin-resistant Staphylococcus aureus at a midwestern hospital: the emergence of \u201ccommunity-associated\u201d MRSA. Am J Infect Control. 2009;37(6):454\u20137.","journal-title":"Am J Infect Control"},{"issue":"7","key":"202_CR52","first-page":"593","volume":"22","author":"G Martinez-Aguilar","year":"2003","unstructured":"Martinez-Aguilar G, Hammerman WA, Mason Jr EO, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003;22(7):593\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"202_CR53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1592\/phco.25.2.253.56956","volume":"25","author":"SA Grim","year":"2005","unstructured":"Grim SA, Rapp RP, Martin CA, Evans ME. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Pharmacotherapy. 2005;25(2):253\u201364.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"202_CR54","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/AAC.01504-08","volume":"53","author":"G Euba","year":"2009","unstructured":"Euba G, Murillo O, Fernandez-Sabe N, et al. Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. Antimicrob Agents Chemother. 2009;53(6):2672\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"202_CR55","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"\u2022\u2022 Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18\u201355. These recently-released guidelines from the Infectious Diseases Society of America include detailed recommendations on the treatment of MRSA osteomyelitis in children.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"202_CR56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jac\/dkn513","volume":"63","author":"WE Rose","year":"2009","unstructured":"Rose WE, Poppens PT. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus. J Antimicrob Chemother. 2009;63(3):485\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"202_CR57","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","volume":"115","author":"DP Levine","year":"1991","unstructured":"Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med. 1991;115(9):674\u201380.","journal-title":"Ann Intern Med"},{"issue":"7","key":"202_CR58","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1086\/605572","volume":"49","author":"S Deresinski","year":"2009","unstructured":"Deresinski S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis. 2009;49(7):1072\u20139.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"202_CR59","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/j.ijid.2009.10.002","volume":"14","author":"J Dotis","year":"2010","unstructured":"\u2022 Dotis J, Iosifidis E, Ioannidou M, Roilides E. Use of linezolid in pediatrics: a critical review. Int J Infect Dis. 2010;14(8):e638\u201348. This is a thorough review of the safety and efficacy of linezolid for a variety of infections in children, including osteomyelitis.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"202_CR60","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/INF.0b013e31812e62dc","volume":"26","author":"C-J Chen","year":"2007","unstructured":"Chen C-J, Chiu C-H, Lin T-Y, et al. Experience with linezolid therapy in children with osteoarticular infections. Pediatr Infect Dis J. 2007;26(11):985\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"202_CR61","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00402-008-0772-x","volume":"129","author":"DAK Rice","year":"2009","unstructured":"Rice DAK, Mendez-Vigo L. Daptomycin in bone and joint infections: a review of the literature. Arch Orthop Trauma Surg. 2009;129(11):1495\u2013504.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"6","key":"202_CR62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijantimicag.2010.07.008","volume":"36","author":"M Lefebvre","year":"2010","unstructured":"Lefebvre M, Jacqueline C, Amador G, et al. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis. Int J Antimicrob Agents. 2010;36(6):542\u20134.","journal-title":"Int J Antimicrob Agents"},{"issue":"29","key":"202_CR63","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1021\/ja8029448","volume":"130","author":"A Villegas-Estrada","year":"2008","unstructured":"Villegas-Estrada A, Lee M, Hesek D, et al. Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics. J Am Chem Soc. 2008;130(29):9212\u20133.","journal-title":"J Am Chem Soc"},{"issue":"Suppl 1","key":"202_CR64","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0163-4453(09)60004-9","volume":"59","author":"GM Eliopoulos","year":"2009","unstructured":"Eliopoulos GM. Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria. J Infect. 2009;59 Suppl 1:S17\u201324.","journal-title":"J Infect"},{"issue":"Suppl 3","key":"202_CR65","doi-asserted-by":"crossref","first-page":"iii11","DOI":"10.1093\/jac\/dkr095","volume":"66","author":"JB Laudano","year":"2011","unstructured":"Laudano JB. Ceftaroline fosamil: a new broad-spectrum cephalosporin. J Antimicrob Chemother. 2011;66 Suppl 3:iii11\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"202_CR66","unstructured":"ClinicalTrials.gov NIoH. Study of blood levels of ceftaroline fosamil in children who are receiving antibiotic therapy in the hospital. [cited Accessed May 2011. Available from: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01298843 ]."},{"issue":"8","key":"202_CR67","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/jac\/dkq193","volume":"65","author":"C Jacqueline","year":"2010","unstructured":"\u2022 Jacqueline C, Amador G, Caillon J, et al. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis. J Antimicrob Chemother. 2010;65(8):1749\u201352. This paper describes the use of ceftaroline, a new 5th-generation cephalosporin with MRSA activity, in an animal model of osteomyelitis.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"202_CR68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2958.1994.tb00304.x","volume":"11","author":"D McDevitt","year":"1994","unstructured":"McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol. 1994;11(2):237\u201348.","journal-title":"Mol Microbiol"},{"issue":"12","key":"202_CR69","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1086\/324430","volume":"184","author":"E Josefsson","year":"2001","unstructured":"Josefsson E, Hartford O, O\u2019Brien L, et al. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis. 2001;184(12):1572\u201380.","journal-title":"J Infect Dis"},{"issue":"8","key":"202_CR70","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1128\/AAC.00096-06","volume":"50","author":"JJ Weems Jr","year":"2006","unstructured":"Weems Jr JJ, Steinberg JP, Filler S, et al. Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2006;50(8):2751\u20135.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"202_CR71","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1128\/IAI.73.8.5229-5232.2005","volume":"73","author":"PJ Domanski","year":"2005","unstructured":"Domanski PJ, Patel PR, Bayer AS, et al. Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus. Infect Immun. 2005;73(8):5229\u201332.","journal-title":"Infect Immun"},{"issue":"2","key":"202_CR72","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1542\/peds.2008-0596","volume":"123","author":"T Zaoutis","year":"2009","unstructured":"\u2022\u2022 Zaoutis T, Localio AR, Leckerman K, et al. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics. 2009;123(2):636\u201342. This large retrospective cohort study clearly showed that an early transition to oral antimicrobial therapy avoided the risk of prolonged parenteral therapy without increasing the risk of treatment failure.","journal-title":"Pediatrics"},{"issue":"6","key":"202_CR73","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1542\/peds.99.6.846","volume":"99","author":"H Peltola","year":"1997","unstructured":"Peltola H, Unkila-Kallio L, Kallio MJ. Simplified treatment of acute staphylococcal osteomyelitis of childhood. The Finnish Study Group. Pediatrics. 1997;99(6):846\u201350.","journal-title":"Pediatrics"},{"key":"202_CR74","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2334-2-16","volume":"2","author":"N Saux Le","year":"2002","unstructured":"Le Saux N, Howard A, Barrowman NJ, et al. Shorter courses of parenteral antibiotic therapy do not appear to influence response rates for children with acute hematogenous osteomyelitis: a systematic review. BMC Infect Dis. 2002;2:16.","journal-title":"BMC Infect Dis"},{"key":"202_CR75","unstructured":"Barrier A, Connelly M, Williams D, et al. Complications of peripherally-inserted central catheters for antibiotic administration. In: Pediatric hospital medicine conference. 2010. Minneapolis, MN."},{"issue":"3","key":"202_CR76","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/QCO.0b013e3283005441","volume":"21","author":"S Weichert","year":"2008","unstructured":"Weichert S, Sharland M, Clarke NM, Faust SN. Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis. 2008;21(3):258\u201362.","journal-title":"Curr Opin Infect Dis"},{"issue":"12","key":"202_CR77","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/INF.0b013e3181f55a89","volume":"29","author":"H Peltola","year":"2010","unstructured":"\u2022\u2022 Peltola H, P\u00e4\u00e4kk\u00f6nen M, Kallio P, et al. Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood: prospective, randomized trial on 131 culture-positive cases. Pediatr Infect Dis J. 2010;29(12):1123\u20138. This randomized trial found that a 20-day course of antibiotic therapy, with only a short period administered parenterally, was as effective as longer courses. However, this may not be directly applicable to populations with high rates of CA-MRSA, which was not a pathogen in this study.","journal-title":"Pediatr Infect Dis J"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0202-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-011-0202-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-011-0202-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:30:27Z","timestamp":1712622627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-011-0202-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,26]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1007\/s11908-011-0202-z","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,26]]}}}